Helping Hispanic children with cancer join clinical trials through parent support
Official title: Multisite Implementation of COMPRENDO (ChildhOod Malignancy Peer REsearch NavigatiOn) to improve participation of Hispanic children in cancer clinical trials
Funded at University of California, San Diego · NIH-11128569 · Data updated 2026-11-12
This project helps parents of Hispanic children with cancer understand clinical trials better, so more children can join these important treatment opportunities.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project start | July 26, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $663,439 |
| NIH project number | 5R01CA279945-03 |
| Project ID | NIH-11128569 on NIH RePORTER |
Who could benefit from this research
✓Could help
This project is designed to support Hispanic children with cancer and their parents or guardians who are considering participation in clinical trials.
✕Less likely to help
Patients who are not Hispanic or whose families are not interested in clinical trial participation may not directly benefit from this specific peer navigation program.
What this research studies
Childhood cancer is a leading cause of death for children, and Hispanic children often face lower survival rates and are less likely to join clinical trials. This project introduces COMPRENDO, a program where trained parents provide culturally sensitive, language-appropriate information to other parents about cancer research. The goal is to help families feel more confident and informed when considering clinical trials for their children. By improving how families understand and access research, we hope to reduce disparities in cancer care for Hispanic children.
Why it matters
Potential benefit: If successful, this program could lead to more Hispanic children with cancer participating in clinical trials, potentially improving their survival rates and reducing health disparities.
How similar studies have gone: This project builds upon a previously developed peer navigation intervention, adapted from evidence-based patient navigation models that have shown success in other healthcare settings.
Where this research is happening
-
University of California, San Diego
La Jolla, United States Active
Researchers
- Principal investigator: Aristizabal, Paula — University of California, San Diego
- Study coordinator: Aristizabal, Paula
Related research
Other NIH-funded projects on the same topics.
-
Detecting cancer risk and treatment response in NF1 nerve tumors using cfDNA markers
A doctor-led study will test blood-based DNA markers to detect when NF1-related nerve tumors become malignant and to monitor how well treatment is working.
-
Epigenetic Basis for Controlling Aggressive IDH-Mutant Gliomas
Aims to understand and shape the epigenetic changes in IDH-mutant brain tumors to restrain their growth, which could lead to new, targeted treatment options for patients.
-
US–East Africa center to prevent and detect virus-linked cancers in people with HIV
This program builds a US–East Africa research network to train local investigators and improve prevention, earlier detection, and faster connection to care for virus-related cancers in people with HIV.
-
U.S.–East Africa program to prevent, detect early, and link people with HIV-related cancers to care
This program brings U.S. and East African teams together to help people with HIV by improving prevention, earlier detection, and faster connection to care for cancers linked to the virus.
-
U.S.–East Africa center to prevent and find HIV-related cancers and speed connection to care
This program builds a U.S.–East Africa team to improve prevention, earlier detection, and faster linkage to care for people with HIV at risk for cervical cancer and Kaposi’s sarcoma.
-
Boosting TET Activity to Help Treat AML with Vitamin C
Vitamin C may help people with a type of blood cancer (AML) by boosting a natural anti-cancer pathway, potentially improving outcomes for adults with this disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.